Our offerings

We deliver insights across the biopharma value chain

Target & Biomarker Discovery

Uncover new biology with multimodal data and AI

Aignostics approach

We use archival tissue to generate custom, multimodal research cohorts on demand. These cohorts are methodically explored with advanced techniques like “explainable AI” to holistically identify novel targets and biomarkers based on multiple levels of biology, including:

  • Clinical metadata
  • H&E / IHC
  • mIF
  • Spatial Transcriptomics
  • Proteomics
  • scRNA-seq
  • Methylomics
Collaboration

Aignostics signs multiyear target & biomarker discovery collaboration with Bayer

Bayer and Aignostics are co-developing a scalable platform for target and biomarker discovery.

Translational Research

Generate quantitative and predictive AI models

Aignostics approach

We have years of experience supporting complex translational research questions across a range of data modalities, including:

  • Comprehensive tissue profiling and spatial analyses for H&E, mIF, and spatial transcriptomics images (e.g., cell classification, niche characterization, etc.)
  • Precise quantification for challenging biomarkers in IHC images (e.g., staining intensity and localization)
  • Prediction of biomarker expression and molecular mutations from H&E images

Digital Diagnostics

Refine AI models for real world use in trials and clinics

Aignostics approach

We work with partners to validate and launch digital diagnostic tools that are developed in the context of translational research, including:

  • Prescreening tools to determine if patients would benefit from additional diagnostic testing
  • Scoring tools to accurately quantify complex biomarkers
  • Positioning tools to determine what therapy a patient is most likely to benefit from
/CERTIFICATION

ISO 13485 and 27001 certified

GCP-ready clinical trial platform

Advance your drug development pipeline with machine learning